High‐resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx

Gene amplifications and deletions are frequent in head and neck squamous cell carcinomas (SCC) but the association of these alterations with gene expression is mostly unknown. Here, we characterized genome‐wide copy number and gene expression changes on microarrays for 18 oral tongue SCC (OTSCC) cell lines. We identified a number of altered regions including nine high‐level amplifications such as 6q12‐q14 (CD109, MYO6), 9p24 (JAK2, CD274, SLC1A1, RLN1), 11p12‐p13 (TRAF6, COMMD9, TRIM44, FJX1, CD44, PDHX, APIP), 11q13 (FADD, PPFIA1, CTTN), and 14q24 (ABCD4, HBLD1, LTBP2, ZNF410, COQ6, ACYP1, JDP2) where 9% to 64% of genes showed overexpression. Across the whole genome, 26% of the amplified genes had associated overexpression in OTSCC. Furthermore, our data implicated that OTSCC cell lines harbored similar genomic alterations as laryngeal SCC cell lines we have previously analyzed, suggesting that despite differences in clinicopathological features there are no marked differences in molecular genetic alterations of these two HNSCC sites. To identify genes whose expression was associated with copy number increase in head and neck SCC, a statistical analysis for oral tongue and laryngeal SCC cell line data were performed. We pinpointed 1,192 genes that had a statistically significant association between copy number and gene expression. These results suggest that genomic alterations with associated gene expression changes play an important role in the malignant behavior of head and neck SCC. The identified genes provide a basis for further functional validation and may lead to the identification of novel candidates for targeted therapies. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045‐2257/suppmat. © 2008 Wiley‐Liss, Inc.

[1]  K. Kok,et al.  Amplicon Mapping and Expression Profiling Identify the Fas-Associated Death Domain Gene as a New Driver in the 11q13.3 Amplicon in Laryngeal/Pharyngeal Cancer , 2007, Clinical Cancer Research.

[2]  Zhi‐hua Liu,et al.  Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray. , 2007, Human pathology.

[3]  A. Kallioniemi,et al.  High-level amplification at 17q23 leads to coordinated overexpression of multiple adjacent genes in breast cancer , 2007, British Journal of Cancer.

[4]  K. Kok,et al.  High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications , 2007, Human Genetics.

[5]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[6]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[7]  O. Kallioniemi,et al.  Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses , 2006, Oncogene.

[8]  T. Godfrey,et al.  Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma , 2006, Genes, chromosomes & cancer.

[9]  D. Gisselsson,et al.  Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma , 2006, Cytogenetic and Genome Research.

[10]  D. Vynios,et al.  Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma. , 2006, Biochimica et biophysica acta.

[11]  M. Brose,et al.  Genome‐Wide Profiling of Oral Squamous Cell Carcinoma by Array‐Based Comparative Genomic Hybridization , 2006, The Laryngoscope.

[12]  J. Schouten,et al.  Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. , 2006, Archives of otolaryngology--head & neck surgery.

[13]  David I. Smith,et al.  Common fragile sites, extremely large genes, neural development and cancer. , 2006, Cancer letters.

[14]  Chu Chen,et al.  Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma , 2005, Cancer.

[15]  Cathie Garnis,et al.  Multiple microalterations detected at high frequency in oral cancer. , 2005, Cancer research.

[16]  J. Greenman,et al.  Unraveling the Chromosomal Aberrations of Head and Neck Squamous Cell Carcinoma: A Review , 2005, Annals of Surgical Oncology.

[17]  I. Ellis,et al.  A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes , 2005, Oncogene.

[18]  J. Fridlyand,et al.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma , 2005, Oncogene.

[19]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[20]  A. Batistatou,et al.  Integrins in Head and Neck Squamous Cell Carcinoma (HNSCC): A Review of the Current Literature , 2005, Cell communication & adhesion.

[21]  T. Hudson,et al.  Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogenously staining region , 2004, Molecular carcinogenesis.

[22]  M. Ichihara,et al.  Expression of CD109 in human cancer , 2004, Oncogene.

[23]  J. Inazawa,et al.  Alteration in Copy Numbers of Genes as a Mechanism for Acquired Drug Resistance , 2004, Cancer Research.

[24]  Jaakko Astola,et al.  A strategy for identifying putative causes of gene expression variation in human cancers , 2004, J. Frankl. Inst..

[25]  J. Cheville,et al.  B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma. , 2003, Cancer research.

[26]  Jaakko Astola,et al.  CGH-Plotter: MATLAB toolbox for CGH-data analysis , 2003, Bioinform..

[27]  Xiang Guo,et al.  Head and neck cancers. , 2003, Cancer chemotherapy and biological response modifiers.

[28]  M. Ringnér,et al.  Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.

[29]  R. Hynes.  A reevaluation of integrins as regulators of angiogenesis , 2002, Nature Medicine.

[30]  S. Nedvetzki,et al.  CD44 in Cancer , 2002, Critical reviews in clinical laboratory sciences.

[31]  R. Uppaluri,et al.  Transcript map of the 8p23 putative tumor suppressor region. , 2001, Genomics.

[32]  S. Gollin.  Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease , 2001, Head & neck.

[33]  Hur-Li Lee,et al.  What is a collection? , 2000, J. Am. Soc. Inf. Sci..

[34]  S. Petersen,et al.  Genetic imbalances with impact on survival in head and neck cancer patients. , 2000, The American journal of pathology.

[35]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[36]  R. Lotan,et al.  Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. , 1996, Cancer research.

[37]  C. Croce,et al.  FHIT gene alterations in head and neck squamous cell carcinomas. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Bartek,et al.  High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.

[39]  S. Piantadosi,et al.  Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization , 1996, Cancer research.

[40]  H. Joensuu,et al.  UT-MUC-1, a new mucoepidermoid carcinoma cell line, and its radiosensitivity. , 1992, Archives of otolaryngology--head & neck surgery.